SV2A and epilepsy: The latter can reduce the action potential and prolong its duration, promote the increase of the refractory period of neurotransmission, and block the abnormal discharge of neurons by adjusting the activity of multiple nerve ion channels; it also specifically binds to the synaptic vesicle protein SV2A to inhibit epilepsy amplification effects [22].